Ginkgo Bioworks Holdings Inc
NYSE:DNA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
Ginkgo Bioworks Holdings Inc (DNA) under the Base Case is 3.86 USD per share.
Compared with the current market price of 8.5 USD, the stock appears
Overvalued by 55% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Ginkgo Bioworks Does
Ginkgo Bioworks builds and programs cells for other companies. It uses genetics, automation, and lab software to design microbes that can make useful ingredients, chemicals, materials, or help with testing and diagnostics. In simple terms, it is a synthetic biology company that helps turn biology into an engineering process.
- Headquarters
- United States of America US
- Employees
- 485
- IPO date
- Apr 19, 2021
Ginkgo Bioworks Holdings has no economic moat
Ginkgo Bioworks Holdings Inc lacks an economic moat, leaving it vulnerable to competitive pressures and market challenges.
Read the full moat analysisContinue DNA Research
Decided on Ginkgo Bioworks Holdings? Get an email when DNA reaches the price you’d buy at. Free with an account.
What is the Intrinsic Value of one DNA stock?
The intrinsic value for
Ginkgo Bioworks Holdings Inc (DNA) under the Base Case is 3.86 USD.
Is DNA stock undervalued or overvalued?
Compared with the current market price of 8.5 USD, the stock appears Overvalued by 55% .